Biotech Firm Prothena Prepares for Potential Sale bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
Biogen Inc. shares slipped in the extended session Thursday after the Food and Drug Administration granted a soon-to-be Novartis AG spinoff approval for the.
Biogen Weighs Takeover of $4 Billion Drugmaker Reata bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
Reata received FDA approval in February for Skyclarys, the first approved treatment for Friedreich’s ataxia, a disease that causes impaired walking and coordination in children.